ANNA BILLY: Open Payments
NPI 1972254126 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 11 payments from 10 companies in 2025. Trend: 2023 $1,861 · 2024 $1,504 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 2 | $39 |
| ARRAY BIOPHARMA INC | 1 | $30 |
| TerSera Therapeutics LLC | 1 | $30 |
| Eisai Inc. | 1 | $29 |
| Tempus AI, Inc | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Syndax Pharmaceuticals, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: REBLOZYL, BRAFTOVI, Zoladex, Lenvima, XT CDX, OJJAARA, IMBRUVICA, MONOFERRIC.
Industry payments across OH — which companies pay providers there.
